Original article
Attitude of physicians toward patient package inserts for medication information in Belgium

https://doi.org/10.1016/0738-3991(96)00866-XGet rights and content

Abstract

In Belgium, the distribution of medications to outpatients in community pharmacies is almost exclusively by branded unit-of-use packages, with a package insert inside every package. At the time of the study (spring 1990), the implementation of legislation that mandated a shift from highly technical documents to patient package inserts (PPIs), understandable by the lay person, had begun. This study explores the attitude of practising physicians toward written medication information for patients. A mail questionnaire was sent to 1500 (8% random sample) Belgian general practitioners and to 500 (22% random sample) internal medicine specialists. A total of 543 usable questionnaires were returned (27.5% return rate). Ninety-two percent of the physicians stated that their patients seldom or never requested additional information on drug efficacy or side effects, during routine consultation; 30% estimated that more than half of their patients read the PPI; 75% expect that a patient would experience side effects after reading about them in the PPI; 59% agreed that the PPI could help the patient react more adequately in unforeseen situations. It was possible to cluster the respondents in a stable segmentation of three clusters: moderately positive physicians (20%), ambiguous to neutral physicians (44%), physicians overtly negative to written drug information (36%). The low response rate to this extensive postal questionnaire limits the conclusions to a qualitative description of relevant clusters of respondents. In contrast with the opinion of physicians about patient readership, results from other studies indicate that the vast majority of patients read the package inserts.

References (32)

  • HJ Baldwin et al.

    Opinion leadership in medication information

    Commun Q

    (1987)
  • VL Culbertson et al.

    Consumer preferences for verbal and written medication information

    Drug Intell Clin Pharmacol

    (1988)
  • LF Tice

    Tice on patient package inserts

    Am Pharm

    (1978)
  • W. Modell

    How to stuff a stuffer and cook a wolf

    Clin Pharmacol Ther

    (1967)
  • C Keown et al.

    Attitudes of physicians, pharmacists and laypersons toward seriousness and need for disclosure of prescription drug side effects

    Health Psychol

    (1984)
  • PH Joubert et al.

    Attitudes of private medical practitioners towards package inserts and other drug information sources

    S Afr Med J

    (1984)
  • Cited by (18)

    • Attitudes and perceptions of Dutch veterinarians on their role in the reduction of antimicrobial use in farm animals

      2015, Preventive Veterinary Medicine
      Citation Excerpt :

      In human medicine, prescribing decisions of physicians are influenced by clinical reasoning as well as non-clinical factors which are related to personal characteristics (e.g., years in practice, extent of medical knowledge, attitudes, relationship with patients) (Akkerman et al., 2005). Knowledge of these prescribing determinants and categorization of health care providers into different target groups is extensively used for the purpose of sustainable implementation of tailored antibiotic stewardship programs and interventions (Hulscher et al., 2010a,b; Kumar et al., 2003; Walker et al., 2001; Vander Stichele et al., 1996; Simpson et al., 2007). Earlier qualitative research amongst Dutch farm animal veterinarians identified a broad variety of opinions regarding veterinary antibiotic use and ways to promote prudent use as well as determinants that influenced their prescribing behaviour (Speksnijder et al., 2015a).

    • Pharmacist, general practitioner and consumer use of written medicine information in Australia: Are they on the same page?

      2014, Research in Social and Administrative Pharmacy
      Citation Excerpt :

      Past negative experiences such as consumers declining CMI when offered, concerns or failure to take medicines after reading CMI (which may be valid and appropriate actions) may pose barriers and interfere with the successful adoption by GPs and pharmacists of CMI in everyday practice. Many GPs (89%) and pharmacists (92%) reported situations where consumers had concerns or queries after reading CMI, resulting in consumers refusing to take or ceasing their medicine, reflecting an earlier study with physicians.46 Notwithstanding these results and accounts in the literature of a relationship between side effect fear and ceasing medication,47 very few consumer respondents in this study reported refusing to take or ceasing their prescribed medicine, possibly inferring a confidence in their practitioners treatment decisions.

    • Pharmacist and general practitioner ambivalence about providing written medicine information to patients-A qualitative study

      2013, Research in Social and Administrative Pharmacy
      Citation Excerpt :

      Studies in the past have shown that patients want information about their medicines.36 Despite principled support for the provision of written medicine information, healthcare professionals often use written medicine information discriminately and infrequently, doubting its usefulness and impact on adherence,37,38 and may perceive written medicine information as a threat to medical expertise and authority.39,40 A shift toward greater patient involvement, the Internet and ready access to health information has also fundamentally challenged the healthcare professional–patient relationship,39 potentially replacing the face-to-face interaction with an impersonal exchange of information through electronic or print media.

    View all citing articles on Scopus

    This study was presented at the 30th Annual Meeting of the Drug Information Association, ‘Health Care Systems in Transition: A Challenge for Innovation’, Washington DC, June 5–9, 1994.

    View full text